Opioids Provide Only Minor Short-Term Relief for Acute Pain, Largest Review Finds
The world's largest review of opioid use for acute pain, published in June 2026, found that these drugs often deliver only minor, short-lived relief and may not be effective for many common conditions. Researchers analyzed data from thousands of patients across multiple pain types.
The largest review ever conducted on the use of opioids for acute pain concluded that these drugs often provide only minor, short-lived relief and may not be effective for many of the conditions for which they are commonly prescribed.
The review, published in June 2026, analyzed data from thousands of patients treated for a range of acute pain conditions, including dental pain, back injuries, and post-surgical discomfort. Researchers found that opioids frequently outperformed placebo by only a small margin and that the benefit often faded within hours.
For some conditions, non-opioid alternatives such as ibuprofen, acetaminophen, or nerve blocks performed as well or better than opioids, with fewer side effects and no risk of dependence.
The findings add to a growing body of evidence challenging the widespread use of opioids for short-term pain management. Researchers said the results should prompt doctors to reconsider prescribing opioids as a first-line treatment for acute pain and to discuss the limited evidence with patients before prescribing.
The review did not address chronic pain, where the evidence on opioid use is different and more complex.
Public health officials said the findings are relevant to ongoing efforts to reduce opioid prescribing and address the addiction crisis. More than 80,000 Americans died from opioid overdoses in 2024, according to the Centers for Disease Control and Prevention.
Researchers called for updated clinical guidelines that reflect the new evidence and for more investment in non-opioid pain management strategies.
